(May 24, 2016)  NeuroQuest Inc. (www.neuroquest.ca), and its joint-venture partner Concept 2 Clinic Inc. (www.concept2clinic.com) (together, “Company”) today announced that the results from an extensive market research highlight the need for new treatment options for neuropathic pain (NP). Details from the study indicated that currently approved drugs have low efficacy and/or result in severe side effects, especially for orally given drugs,...